Suchergebnisse - "angiotensin II type1 receptor blockers"

PubPharm (1.285)

1

Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status : A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study

enthalten in: Journal of the American Heart Association | 2023

von Kario, K. | Rakugi, H. | Yarimizu, D. | +3

2

Angiotensin II Regulates the Neural Expression of Subjective Fear in Humans : A Precision Pharmaco-Neuroimaging Approach

enthalten in: Biological psychiatry. Cognitive neuroscience and neuroimaging | 2023

von Zhang, R. | Zhao, W. | Qi, Z. | +3

CommentIn: Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Mar;8(3):233-234. - PMID 36889867

3

Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease : The TELEX Randomized Clinical Trial

enthalten in: JAMA | 2022

von McDermott, M. | Bazzano, L. | Peterson, C. | +13

CommentIn: JAMA. 2022 Oct 4;328(13):1302-1303. - PMID 36194236

4

Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia : A double-blind, placebo-controlled cross-over trial (the PALM study)

enthalten in: Pregnancy hypertension | 2022

von Zoet, G. | Paauw, N. | Veerbeek, J. | +5

5

Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury : A Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Puskarich, M. | Ingraham, N. | Merck, L. | +33

ErratumIn: JAMA Netw Open. 2022 May 2;5(5):e2215958. - PMID 35579901

6

Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan

enthalten in: Clinical pharmacology in drug development | 2021

von Huh, K. | Lee, S. | Lee, S. | +3

7

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria : An IRMA2 sub-study

enthalten in: Diabetic medicine : a journal of the British Diabetic Association | 2021

von Piazza, M. | Hanssen, N. | Persson, F. | +8

8

The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19

enthalten in: Obesity (Silver Spring, Md.) | 2021

von de Ligt, M. | Hesselink, M. | Jorgensen, J. | +3

9

Urinary peptidome and diabetic retinopathy in the DIRECT-Protect 1 and 2 trials

enthalten in: Diabetic medicine : a journal of the British Diabetic Association | 2021

von Rotbain Curovic, V. | Magalhães, P. | He, T. | +4

10

Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria : A prospective, randomized, open-label, blinded endpoint (PROBE) study

enthalten in: PLoS medicine | 2021

von Ruggenenti, P. | Cortinovis, M. | Parvanova, A. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[129]